Concanavalin-A conjugated fine-multiple emulsion loaded with 6-mercaptopurine.
Fine-multiple (water-in-oil-in-water) emulsions were prepared by two-step emulsification using sonication. They were coated with concanavalin-A (Con-A) by three methods. The one involving covalent coupling of Con-A to the multiple emulsion incorporated anchor was better compared with lipid derivatized Con-A anchoring or the glutaraldehyde-based cross-linking method, as shown by the faster rate of dextran-induced aggregation. The selected multiple emulsions were characterized by physical properties such as droplet size, encapsulation efficiency, and zeta potential. Stability parameters such as droplet size, creaming, leakage, and aggregation as a function of relative turbidity were monitored over a 1-month period, which revealed good stability of the formulations. The release profile of 6-mercaptopurine followed zero-order kinetics. Pharmacokinetic studies showed an increase in half-life and bioavailability from multiple emulsion formulations administered intravenously. There was prolonged retention of drug in various tissues of rats when treated with Con-A-coated multiple emulsion as compared with uncoated one. Our study demonstrates the suitability of fine-multiple emulsion for intravenous administration and the potential for prolonged retention of drugs and targeting in biological systems.
Khopade
A J
AJ
Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar, India.
Jain
N K
NK
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003208:Concanavalin A / Q000008:administration & dosage*; D004655:Emulsions; D005260:Female; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000964:Antimetabolites, Antineoplastic; D004655:Emulsions; D003208:Concanavalin A; D015122:Mercaptopurine